tqb3454
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 24, 2020 (NCT04481607)
Timeline
Indications
Mechanism of action
IDH1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06139367 | Phase 1 | Nov 30, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT05987358 | Phase 3 | Oct 31, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06218771 | Phase 1/Phase 2 (Phase 2) | Jul 10, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT04481607 | Phase 1 | Aug 24, 2020 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | For profit | 4 | 4 | 3 | 2020 |
1 organizations
Page 1 / 1